The Biologics World Taiwan 2016 conference, held on February 25-26 in Taipei, focused on collaboration in the biopharmaceutical sector, showcasing advancements and strategies to elevate Taiwan's biotech firms globally. The event featured prominent speakers from various multinational firms and Taiwanese biotech companies discussing trends, development strategies, and challenges facing the industry. Attendees included R&D leaders, CEOs, and industry professionals, emphasizing the conference's role in fostering networking and knowledge sharing.

1. 25 – 26 February, 2016 | Taipei, Taiwan
Emphasizes on new business
collaborations, demonstrate state-
of-the-art developments and to
propel Taiwan's biotech firms onto
the world stage.
1
The ONLY biopharmaceutical
gathering in Taiwan
DISTINGUISHED PANEL OF SPEAKERS
Dr. Wei-Kuang Chi
Distinguised Scientist,
Development Centre
for Biotechnology
Dr. Jian Li
Director, External Science
& Partnering (Asia Pacific)
Sanofi Global R&D
Dr. Hunchi Lin
President,
Global BioPharma
Dr. Nathan Chen
VP, Chief Medical Officer
& Head of Global Medicine
Development, OBI Pharma
Dr. Judy Chou
Vice President,
Technical Operations
Medivation Inc.
Dr. Junichi Nezu
Research Head,
Chugai Pharmabody
Research
Dr. Eskouhie Tchaparian
Director, Preclinical &
Clinical Development,
Holy Stone Healthcare
Dr. Chaosheng Cheng
Director of Biologics
Manufacturing,
PharmaEssentia
Dr. Chih-Hsiang Leng
Deputy Director,
National Institute of Infectious
Diseases and Vaccinology
Dr. Jiali Luo
VP & General Manager,
Boehringer Ingelheim
Biopharmaceuticals
(China) Ltd Co.
Dr. Bin Chen
Director & China Biologics
Scientific Leader, Janssen
BioTherapeutics of Janssen R&D
Dr. Nan-Horng Lin
Senior VP,
Head of R&D,
CHO Pharma
Dr. Yuan-Hua Ding
External R&D Innovation
(ERDI) - Asia Pacific,
Pfizer
Dr. Michael Chang
Chairman,
OBI Pharma
Dr. Herng-Der Chern
Chief Medical Officer,
Taiwan Supra Integration
and Incubation Centre
Scientific Advisory Board
Taiwanese Biologics & Biotechs Multinational Biopharmas
Proudly Created
& Produced By:
Gold Sponsor: Exhibitors: Association Partners: Media Partners:
W: www.imapac.com/business_conference/biologics-world-taiwan-2016/ E: justin.dejesus@imapac.com C: +65 3109 0129

2. Biologics World Taiwan 2016 25 - 26 February, 2016 | Taipei, Taiwan
Attendee Profile Breakdown
AGENDA AT A GLANCE
Day 2Day 1
Taiwan’s Biologics Industry Trend
and Updates
Process Development
and PAT
Protein Analytics and
Characterization
Cell Line Selection
& Cell Culture
Engineering
Downstream
Processing
Protein Engineering for Improved
Bioavailability and Efficacy
Innovation Showcase:
mAbs & recombinant proteins
Innovation Showcase: Novel Biologics &
Vaccines Development
Partnership Strategies for
Global Expansion
Early-stage & Late-stage,
Multiregional Clinical Trials
Afternoon Session
Welcome Cocktails | Conference Closes
Morning Session
Solution
Providers
Others
Local Biopharma-
ceutical firms
Research Institutes
MNCs
20%
55%
10%
2%
13%
By Industry
VPs & Directors of
R&D
VPs & Directors of
Manufacturing
CEOs/CTOs/CSOs/
MDs
R&D Elites & Engineers
Regulatory, Licensing &
Business Development
Others
30%
15%
5%
30%
10%
10%
By Job Title
Taiwan
China
Japan
Korea
India
Europe
USA
Rest of the
World
57%
20%
10%
10%
5%
3%
3%
2%
By Country
2
For speaking opportunities and to find out more
on the program, please contact:
Emma Song
Conference Manager
+65 6493 1601
emma.song@imapac.com
W: www.imapac.com/business_conference/biologics-world-taiwan-2016/ E: justin.dejesus@imapac.com C: +65 3109 0129

3. 8:45 IMAPAC’s Welcome Remarks
TAIWAN'S BIOLOGICS INDUSTRY TREND AND UPDATES
PARTNERSHIP STRATEGIES FOR GLOBAL EXPANSION
8:00 Registration Starts
Chairman’s Opening Remarks8:50
SPEED NETWORKING & MORNING REFRESHMENTS10:00
CONFERENCE DAY 1 25 February 2016
9:00 Evaluating Current Trends of Taiwan’s Biologics Industry: Keeping the Momentum and Moving towards a
Profitable Business Model
Evaluating the risks and opportunities when Taiwan’s biologics are entering into critical stage of global trials
Keep the momentum of Taiwan’s biologics industry: how to get greater fund support and more patience from the investors
How to speed up to move towards profitable business model: from clinical trials to post-trial marketing
Dr. Michael Chang, Chairman, OBI Pharma, Taiwan (Confirmed speaker)
Keynote
9:30
Dr. Herng-Der Chern, Chief Medical Officer, Taiwan Supra Integration and Incubation Center, Taiwan (Confirmed speaker)
Ecosystem Update for Branding Taiwan Biotechnology
Strategy of viewing "Taiwan as a virtual midsize biotech company with opening innovation integration"
Update of biotech ecosystem in Taiwan
Current focus of biologic product development in Taiwan
PROTEIN ENGINEERING FOR IMPROVED BIOAVAILABILITY AND EFFICACY
EARLY-STAGE & LATE-STAGE, MULTIREGIONAL CLINICAL TRIALS
NETWORKING LUNCHEON12:00
10:30 Evaluating the Measures in Establishing an International Co-development Partnership to Share
Responsibilities and Risks in Global Trials
Strategies for sharing clinical data between co-development partners
Balance between risk allocation and profit sharing for collaborating partners
Conducting clinical trials in compliance with international scientific and ethical standards whilst comply to local applicable
laws and regulations
Dr. Ko-chung Lin, CEO & Founder, PharmaEssentia, Taiwan (Confirmed speaker)
11:00
Clearing Legal Obstacles and Preparing for Due Diligence Investigation for Out-licensing
INDUSTRY PRESENTATION
14:00
Advances in Phage and Yeast Display: Selection and Optimization of Highly Developable Antibodies
INDUSTRY PRESENTATION
13:30
Dr. Junichi Nezu, Research Head, Chugai Pharmabody Research, Singapore (Confirmed speaker)
Recycling & Sweeping Antibody Technology and Its Application -- “Antibody Crafting” with High Through-put
Comprehensive Mutagenesis Approach
Limitation of conventional antibody against soluble antigen and membrane-bound antigen
Recycling and sweeping characteristics of SMART-Ig
Application of SMART-Ig to drug discovery
AFTERNOON COFFEE BREAK15:00
Biologics World Taiwan 2016 25 - 26 February, 2016 | Taipei, Taiwan
3
14:30 Recent Development of Multifunctional Antibodies
Reviewing the idea of multifunctional antibodies, bispecific antibodies and more
Development progress of heterodimeric platform and antibody mixture
Two case studies of multifunctional antibodies
Dr. Ting Xu, CEO & President, Alphamab, Mainland China (Confirmed speaker)
CaseStudy
Dr. Bin Chen, Director & China Biologics Scientific Leader, Janssen BioTherapeutics of Janssen R&D, U.S. (Confirmed speaker)
15:30 Key Early Development Efforts to Enable a Successful IND/CTA Submission for Novel Biologics
High level introduction of critical activities in transitioning a novel biologics from discovery to FIH
Highlights on a toxicology and clinical pharmacology program to enable biologics FIH
Considerations in designing FIH studies of novel biologics such as dose selection, PK/ADA assessment, etc
11:30 Road to Successful Out-licensing: How to Get on Big Pharma’s Radar?
Choosing right partners – from big pharma’s perspective
Technical and business considerations in identifying the best match for partnership
Turning the agreement into a living partnership – how to avoid potential pitfalls in the negotiation
PanelDiscussion
Dr. Hunchi Lin, President, Global BioPharma, Taiwan (Confirmed Moderator)
Dr. Jian Li, Director, External Science & Partnering (Asia Pacific), Sanofi Global R&D, Mainland China (Confirmed panelist)
Dr. Zheng Li, General Manager, Head of Research China, Lundbeck, Mainland China (Confirmed panelist)
Dr. Jiali Luo, VP & General Manager, Boehringer Ingelheim BioPharmaceuticals China, Mainland China (Confirmed panelist)
Dr. Yuan-hua Ding, Executive Director, Head of Pfizer External R&D Innovation - Asia, Pfizer, U.S. (Confirmed panelist)
W: www.imapac.com/business_conference/biologics-world-taiwan-2016/ E: justin.dejesus@imapac.com C: +65 3109 0129

4. Biologics World Taiwan 2016 25 - 26 February, 2016 | Taipei, Taiwan
4
PROCESS DEVELOPMENT AND PAT PROTEIN ANALYTICS AND CHARACTERIZATION
8:00 Registration Starts
Chairman’s Opening Remarks8:50
MORNING REFRESHMENTS10:30
Chairman’s Closing Remarks17:00
Conference Day #1 Closes17:10
16:30 Risk-based Approaches for Remote Monitoring in Multinational Clinical Trials
Assessment of risk-based approaches for remote monitoring
Identification of critical data and processes to be monitored
Evaluation of quality and integrity of the data provided by the different sites in multinational trials
Dr. Nathan Chen, VP, Chief Medical Officer & Head of Global Medicine Development, OBI Pharma, Taiwan (Confirmed speaker)
16:00
Participant Recruitment and Retention Strategies for Clinical Trials in Europe and U.S.
INDUSTRY PRESENTATION
9:30
Moving from Batch toward Continuous Manufacturing
of Biologics for Higher Productivity and Consistent
Product Quality
INDUSTRY PRESENTATION
Progress and Applications of Intact Protein Mass
Spectrometry
INDUSTRY PRESENTATION
11:30
Cell Culture Optimization Strategies for CHO to Keep
Cells Growing Longer in Log Phase
INDUSTRY PRESENTATION
An Insight into Protein A Chromatography and
Alternative Methods for Purification
INDUSTRY PRESENTATION
10:00
Process Characterization and Validation for
PEGylated-IFNα 2b
Risk-based Failure Mode and Effect Analysis (FMEA)
method for the initiation of process characterization
Application of QbD in P1101 manufacturing process
Specification of AOR, CPP and CQA
Dr. Chaosheng Cheng, Plant Manager, PharmaEssentia,
Taiwan (Confirmed speaker)
Case Study Case Study
Current Advances in Tools and Assays for the
Characterization of Protein Therapeutics
New protein assay methods for antibody screening and
characterization
Tools and methods to exam protein-protein interaction
Assessing high order structure of protein therapeutics
Dr. Judy Chou, VP of Technical Operations, Medivation
Inc., U.S. (Confirmed speaker)
CONFERENCE DAY 2 26 February 2016
CELL LINE SELECTION & CELL CULTURE ENGINEERING DOWNSTREAM PROCESSING
9:00 Characterization of Protein-based Bio-therapeutics
Stability and Activity During Drug Development
Recent advances in stability and activity characterization of
protein-based bio-therapeutics
Emerging technologies to streamline the development of
protein therapeutics
Native and subunit analysis of antibody-based drug candidates
Dr. Youling Wu, CEO & Founder, Teruisi Pharmaceutical Inc.,
Mainland China (Confirmed speaker)
Examining the Alignment between Research and
Process Functions to Achieve Rapid and Systematic
Tech Transfer and Scale-up
Reviewing current misalignments between research and
process development
How to accelerate the process of tech transfer and scale-up
Possible solutions to better coordinate research and process
function
Dr. Jiali Luo, VP & General Manager, Boehringer Ingelheim
Biopharmaceuticals, Mainland China (Confirmed speaker)
11:00 Cost-effective Strategies in Viral Testing and Clearance
Stressing challenges in developing predictive scale-down
purification models for viral clearance
Efficacy and cost analysis of typical technologies in viral
testing and clearance
Process strategies to improve virus clearance in early
downstream processing
Platform for Efficient Process Development and
Transfers of Biosimilars
Scale-down model for process development to achieve
Biosimilarity
Strategy for technology transfer from process development to
pilot production
Commercial manufacturing production in Wuhan, China
Tim Lin, Director of Cell Culture Process Development, JHL,
Taiwan (Confirmed speaker)
W: www.imapac.com/business_conference/biologics-world-taiwan-2016/ E: justin.dejesus@imapac.com C: +65 3109 0129

5. INNOVATION SHOWCASE: MABS & RECOMBINANT PROTEINS
INNOVATION SHOWCASE: NOVEL BIOLOGICS & VACCINES DEVELOPMENT
NETWORKING LUNCH12:30
AFTERNOON COFFEE BREAK15:00
13:30
Recent Advances of ADXS-HPV for the Treatment of Human Papillomavirus (HPV)-associated Diseases
Dr. Hunchi Lin, President, Global BioPharma, Taiwan (Confirmed speaker)
Case Study
Dr. James Rance, Head of Development Services,
Lonza Biologics Singapore, Singapore (Confirmed speaker)
Dr. Xujia Zhang, VP & Head of E.coli Research China,
Novo Nordisk Research China, Mainland China (Confirmed speaker)
15:30
Hyaluronic Acid (HA) Drug Conjugates for Targeted Delivery of Anticancer Drugs
Dr. Eskouhie Tchaparian, Director, Preclinical & Clinical Development, Holy Stone Healthcare, Taiwan (Confirmed speaker)
Case Study
15:50
Homogeneous Glyco-form for the Improved Function of Therapeutic Antibodies
Dr. Nan-Horng Lin, Senior Vice President, Head of R&D, CHO Pharma, Taiwan (Confirmed speaker)
Case Study
Dr. Chih-Hsiang Leng, Assistant Investigator & Deputy Director, National Institute of Infectious Diseases and
Vaccinology, NHRI, Taiwan (Confirmed speaker)
16:10
Establishment of Lipid-based Immunogens for the Development of Novel Subunit Vaccines
Case Study
13:50
Design of Integrin-Specific Drugs for Cancer
Dr. Woei-Jer Chuang, Distinguised Professor, Department of Biochemistry and Molecular Biology, National Cheng Kung
University College of Medicine, Taiwan (Confirmed speaker)
Case Study
14:10
Dr. Yu-Chan Chao, Research Fellow, Institute of Molecular Biology, Academia Sinica, Taiwan (Confirmed speaker)
Baculovirus as a Highly Effective Vector for Gene Delivery in Mammalian Cells
Case Study
14:30 Q&A
16:30 Q&A
12:00 A Comparative Analysis of Fed-batch and Perfusion
Culture Processes: Economic and Operational
Feasibility
Evaluating current and future potential of batch and
continuous cell culture technologies
Comparative analysis of operational, economic and
environmental feasibility of different systems
Making the right choice: key considerations to keep in mind
Protein Recovery and Purification in E.coli Cell
Culture for Diabetes Therapeutic Development
Comparative analysis of cleaving technologies for purification
tag removal
Gaining efficiency and value during process characterization
Monitoring and controlling critical purification attributes in
protein recovery and purification
5
Biologics World Taiwan 2016 25 - 26 February, 2016 | Taipei, Taiwan
Chairman’s Closing Remarks17:00
Conference Closes17:10
Andrea W. Wu
President, American Chamber of
Commerce in Taipei
IMAPAC conferences
bring together the right people
at the right time on the right
topics. There’s no better time
investment than an IMAPAC
Conference.
Alan Liss
Principal Consultant, GXP farma,
LLC Cosnsulting
Praise from Biologics World Taiwan 2015
Certainly, this is an event
that helps to contribute to
the development of the sector
by allowing key players to
network, share information
and industry insights.
W: www.imapac.com/business_conference/biologics-world-taiwan-2016/ E: justin.dejesus@imapac.com C: +65 3109 0129

6. Biologics World Taiwan 2016 25 - 26 February, 2016 | Taipei, Taiwan
4th Biologics World Taiwan 2016
PARTNER WITH US
WE HAVE SOMETHING FOR EVERYONE
Biologics World Taiwan 2016 is the ONLY event in Taiwan for the region’s biologic drug industry.
Leverage on this year’s best marketing and sales opportunity to access one of the fastest growing
biologics and biosimilars markets in Asia!
Are you a service and or technology provider in this space looking to stay abreast of developments
in this market, continuously build new leads, brand yourself as a solution provider, and grow your
market share? If yes, Biologics World Taiwan 2016 is for you.
What is your company’s key objective in 2016 for the Taiwan biologic drug market? Get in touch
with us about your needs, and we will tailor the best package for you, and ensure that your money
is well spent! Below are the various partnering options that we offer:
WHY SPONSOR BIOLOGICS WORLD TAIWAN 2016?
Pre-Conference: Logo presence on printed brochure, internally generated content,
e-brochure, E-mail blasts, conference website, partner websites, and more!
On-Site: Logo on conference back-drop, on-screen presentations, conference booklet,
material distribution, logo presence on select material, and more!
Company mention before and after the conference.
BRANDING:
Exhibition opportunity
Technology showcase
Material distribution during the event
Conducting a workshop, and more!
EDUCATING THE MARKET:
Exhibition opportunity
Cocktail sponsorship
Lunch sponsorship
Tea break sponsorship
Extra delegate passes
NETWORKING & LEAD GENERATION
Conference chairmanship
Speaking opportunity
Moderating a panel
Facilitating a Q&A session
Presenting a client case study...and more!
THOUGHT LEADERSHIP:
6
Exhibition passes
Client passes
Private one-one meetings, and more!
For sponsorship & exhibition opportunities,
please contact:
W: www.imapac.com/business_conference/biologics-world-taiwan-2016/ E: justin.dejesus@imapac.com C: +65 3109 0129
Ana Laxamana
Sponsorship Sales Manager
Work: +65 3109 0128
ana.laxamana@imapac.com

7. HJB Venture Partners
Hefei Tianmai Biotechnology
Henlius Biotech Co.,LTD
IBTM
IMS Health
INC Research
Institute of Biologics, Development
Center for Biotechnology (DCB)
Industrial Technology Research
Institute
ICON Clinical Research
Inventiv Health Clinical
Janssen R&D USJianshun
Biosciences Co Ltd.
JHL Biotech
Kerry Ingredients & Flavours
Lonza Biologics
Luye Pharma Group Ltd
MD News
Medigen Biotechnology Corp
Merck Serono
Merck Millipore
Meridigen
Ministry of Economic Affairs
Mycenax Biotech Inc.
National Health Research Institutes
National Research Program for
Biopharmaceuticals
National Taiwan Normal University
National Yang Ming University
Nang Kuang Pharmaceutical
NHRI
Nippon
North Carolina Economic
Development Partnership
OBI
Osong Medical Innovation
Foundation
Original BioMedicals Co. Ltd
Parexel International
Past Attendees:
7
Past Attendees of Biologics World Taiwan:
Academia Sincia
Adimmune Corporation
Animal Technoloy Laboratories
ASLAN pharmaceutic
ATMI Lifesciences
Aurora Biotech
Avantor Performance Materials
BD Biosciences
Beigene
BioGENEXUS
Boehringer Ingelheim
Bioguard
Biotech East
Bristol-Myers Squibb (Taiwan) Ltd.
Biotechnology &
Pharmaceutical Industries
Promotion Office
China Times Group
Chugai Pharma Taiwan
Chunghwa Yuming Health (CYH)
Cytovance Biologics
Development Center for
Biotechnology
DHL Express Asia Pacific
Development Centre for
Biotechnology
Eddingpharm
Economic Daily News Gold
Media Group
Eczacibasi Healthcare Group
EirGenix Inc
Eusol Biotech Co. Ltd
Everscience Technology Co. Ltd
F.D. Enterprise Corporation
Federal Express Corporation
Taiwan Branch
Formosa Laboratories
Fountainmab Biopharma
GE Healthcare Life Sciences
General Biologicals Corporation
Pall Life Sciences
PharmaEssentia
Polyplus Transfection SA
Protech Pharmaservices
Corporation
Puricon Biotechnology Inc
Roche Diagnostics Asia Pacific
Pte Ltd
Savior Lifetec
Senhwa Biosciences, Inc.
Sartonets Taiwan Ltd
Sartorius Stedim Singapore
Pte Ltd
Servier (S) Pte Ltd, Taiwan
Branch
Servier Pharmaceutical
Company
Sanofi China
Shanghai CP Guojian
Pharmaceutical
Synermore Biologics
TaiMed Biologics Inc
Taipei Medical University
Taiwan Advance
Biopharmaceutical
Taiwan Liposome Company
Takada Pharmaceuticals
Takeda Development Center
TAP Biosystems
TDW Pharmaceuticals Inc.
TPG Biologics
TRMA
TTY Biopharma Company
The American Chamber of
Commerce in Taipei Limited
TWI Biotechnology Inc
UBI Asia
Unimed Healthcare Inc
United Biomedical Inc
Yuan Ze University
And more...
SAMPLE
LIST
Biologics World Taiwan 2016 25 - 26 February, 2016 | Taipei, Taiwan
W: www.imapac.com/business_conference/biologics-world-taiwan-2016/ E: justin.dejesus@imapac.com C: +65 3109 0129

8. The registration fee includes refreshments, lunch & full conference documentation. The conference fee does not include hotel accomodation.
Special discounts and eligibility: ONLY ONE DISCOUNT SCHEME IS APPLICABLE
INNER CIRCLE:
*Speaker referrals as well as professionals working in the same company as the event speakers are entitled to a 15% discount.
PRIZE FREEZE:
*Clients of all our sponsors and exhibitors can avail the first-tier price throughout the campaign, even after the deadline is passed!
ASSOCIATION MEMBERS:
*10% discount off published delegate conference fee for supporting associations.
GROUP PACKAGES:
*Save 10% for 3 delegates and 20% for 5 delegates.
FOR TAIWANESE BIOLOGICS MANUFACTURERS & TAIWANESE ACADEMICS:
**Buy-2-Get 3 & Buy-3-Get 5 scheme applies
YOUR DETAILS
Name
Job Title
Address
Postcode
Tel
Email
Your primary business
Authorising Manager
By signing and returning this form, you are accepting our terms and conditions.
Organizaton
Country
Fax
Authorising manager signature
PAYMENT DETAILS
Payment is due immediately upon receipt of this registration form if you pay by credit card or 3 working days after
your receipt of payment notification. Non-credit card payment will incur an additional US$100
I want to pay Credit Card Non-credit card and add US$100 booking fee
Offline credit card payment:
Visa MasterCard American Express
Name on Card
Expiry Date
Card Number
Signature
Full payment is due upon registration if you pay by credit card, or 3 working days after receipt of invoice.
Registration will not be confirmed until full payment has been received.
Unpaid registration will be billed 50% of the registration fee if you do not attend the event. A copy of the conference documentation will be mailed to you.
The registration fee includes refreshments, lunches, cocktails and full conference documentation. The conference fee does not include hotel accomodation.
Staff at the event will request a credit card guarantee for delegates without proof of payment.
TERMS CONDITIONS:
CANCELLATION SUBSTITUTION POLICY:
Cancellations must be received in writing. If the cancellation is received more than 14 days before the conference attendees will receive a full credit note to a future conference. Cancellations
received 14 days or less (including the fourteenth day) prior to the conference will be liable for the full fee.
A substitution from the same organisation can be made at any time in writing at no extra charge.
In the event that IMAPAC cancels a conference, payments received at the cancellation date will be credited towards attendance at a future conference or in the event of postponement by IMAPAC,
towards the rescheduled date.
Credit notes remain valid for twelve months.
Registration Form
CHANGES TO CONFERENCE AGENDA: IMAPAC reserves the right to postpone or cancel an event, to change the location or alter the advertised speakers for an event. IMAPAC is not responsible for any loss
or damage as a result of substitution, alteration, postponement or cancellation of an event due to causes beyond its control including without limitation, acts of God, natural disasters, sabotage, accident, trade or
industrial disputes, terrorism or hostilities.
In the event that a conference is cancelled, IMAPAC is not liable for any costs incurred by delegates in connection with their attendance. Control to alter the content and timing of the programme,
venue or the identity of the speakers without any liability to the delegates. Changes to the agenda will be updated on our website as soon as possible.
DATA PROTECTION: The personal information shown and/or provided by you will be held in a database. It may be used to keep you up to date with developments in your industry. Sometimes your details
may be obtained or made available to reputable third parties for marketing purposes. If you do not wish your details to be used for this purpose, please write to: data@imapac.com.
EVENT VENUE
Group Booking
25 - 26 February, 2016
Taipei, Taiwan
Online
The quickest easiest way to
register is online using a credit
card. Visit: http://www.imapac.com/
business_conference/biologics
-world-taiwan-2016/pricing/
registration/
By Fax
Please fax your booking form to
+65 6722 0649
Mail
By cheque made payable to:
IMAPAC PTE. LTD.
Send your team save more!
3 delegates
5 delegates
Call +65 6493 1871 or go online
register at: http://www.imapac.
com/business_conference/
biologics-world-taiwan-2016/
pricing/registration/
Save 10%
Save 20%
4 Easy Ways to Register:
8
Biologics World Taiwan 2016 25 - 26 February, 2016 | Taipei, Taiwan
2 DAYS CONFERENCE PASS
(25-26 FEBRUARY 2016)
LIMITED
SUPER
LIMITED
SPECIAL
EARLY
BIRD
STANDARD
PRICE
General Public
(*Inner Circle, Price Freeze, Association
Members rate and Group Package applies)
Taiwanese Biologics Manufacturers
Taiwanese Academics
(*Inner Circle, Price Freeze,
Association Members rate and
Group Package applies)
USD 2,195 USD 2,395 USD 2,595 USD 2,795
USD 695 USD 895 USD 1,095 USD 1,295BUY 2, Get 3
BUY 3, Get 5
(By 25 Sep 2015) (By 16 Oct 2015) (By 18 Dec 2015)
*To confirm your eligibility for any of the the above discounts, please email Justin De Jesus at justin.dejesus@imapac.com or
call +65-6493 1872 to receive a discount code.
W: www.imapac.com/business_conference/biologics-world-taiwan-2016/ E: justin.dejesus@imapac.com C: +65 3109 0129
Telephone
To register over the phone, please
call us on +65 3109 0129
Send with this booking form to:
IMAPAC PTE. LTD.
133 Cecil Street #05-02A Keck
Seng Tower Singapore 069535
Bank transfer: Payment by bank transfer must quote delegate name and conference name.
For bank details swift code, it will be emailed to you as part of the invoice.
Cheque payment: Crossed cheque payable to IMAPAC Pte Ltd, and mail it in a sealed envelope
to IMAPAC Pte Ltd, 133 Cecil Street #05-02A Keck Seng Tower Singapore 069535
EXPIRED
EXPIRED EXPIRED
EXPIRED